Bureau de presse mondial
Des informations sur le portefeuille étendu et croissant de titres, de travaux et de technologies à la pointe des communautés universitaires, de la recherche et de la santé dans le monde entier.
Partager notre actualité et nos expériences
Nous aidons les chercheurs et les professionnels de la santé à faire progresser la science et améliorer les résultats de santé au profit de la société. Depuis plus de 140 ans, nous sommes l'un des principaux soutiens et partenaires des communautés mondiales de la santé et de la recherche.
Elsevier is a global leader in advanced information and decision support for science and healthcare. For more than 140 years, we’ve helped advance science and healthcare to advance human progress, and that same mission drives us today. We are part of RELX S’ouvre dans une nouvelle fenêtre, a FTSE 10 company and global provider of information-based analytics and decision tools for professional and business customers.
The communities we serve across academia, R&D driven industries and healthcare are working to solve some of the world’s biggest challenges -- we strive to bring them the best solutions and to be the best partner possible for progress. We deliver insights that help research institutions, governments and funders achieve their goals. We help researchers discover and share knowledge, collaborate, and accelerate innovation. We help librarians provide verified, quality information to universities. We help innovators turn knowledge into new medicines and products. We help health professionals improve patient care and educators train the next generation of doctors and nurses.
Our trusted brands include the world’s leading research platforms like ScienceDirect and Scopus, technical databases such as Reaxys for chemicals, best-in-class clinical tools like ClinicalKey and innovative learning platforms such as Sherpath and Osmosis for nursing — all enriched by responsible AI.
Last year, our 3,000+ scientific journals received 3.5 million research papers and published 720K articles after rigorous editorial and peer review, reflecting our focus on quality. This is also reflected in the fact that the research published by Elsevier accounts for 17% of global research articles and 29% of global citations.
Toutes dernières actualités d'Elsevier
Voir tout communiqués de presseCarolina Consortium and Elsevier Announce Transformative Read-and-Publish Agreement
Elsevier supports Pistoia Alliance in accelerating safe and responsible AI adoption in drug discovery
Entretien avec l'un de nos experts
Prenez contact avec l'un de nos collaborateurs pour en savoir plus sur notre travail innovant au service des communautés universitaires, de la recherche et de la santé.
Que vous ayez un délai serré ou que vous recherchiez un nouvel article, le bureau de presse mondial d'Elsevier est là pour vous aider.
